The largest database of trusted experimental protocols

Lipofectamine 2000 reagent

Manufactured by Sangon
Sourced in China

Lipofectamine 2000 reagent is a cationic lipid-based transfection reagent designed for efficient delivery of nucleic acids, such as plasmid DNA, siRNA, or mRNA, into a variety of mammalian cell lines. The reagent forms complexes with the nucleic acids, facilitating their uptake and expression in the target cells.

Automatically generated - may contain errors

7 protocols using lipofectamine 2000 reagent

1

Transfection of Human Osteosarcoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two human OS cell lines U2OS and MG-63 (ATCC, USA) were used in this study. Cells were cultivated in the mixture of 90% Eagle’s minimum essential medium and 10% FBS. Cell culture conditions were 37°C, 95% humidity and 5% CO2. U2OS and MG-63 cell were harvested at confluence of 70-80% to perform cell transfections. Negative control (NC) miRNA and miR-522-3p, NC siRNA and GLUT1 siRNA, as well as GLUT1-expression pcDNA3.1 vector and empty pcDNA3.1 vector were all from Sangon (Shanghai, China). Transient transfections were mediated by lipofectamine 2000 reagent (Sangon) to transfect 40 nM miRNA (NC miRNA as NC group), 40 nM siRNA (NC siRNA as NC group), or 10 nM vector (empty vector as NC group) into 106 (link) cells. Subsequent experiments were performed using cells harvested at 24 hrs post-transfection. Control (C) cells for all transfections were untransfected cells.
+ Open protocol
+ Expand
2

Modulating RUSC1-AS1, Notch1 and miR-101-3p in Osteosarcoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Saos-2 cells and MG-63 cells were seeded in 24-well plates. SiRNA (si-RUSC1-AS1) or of RUSC1-AS1 overexpression plasmids, Notch1 overexpression plasmids, or their negative controls (100 nM, GenePharma, China) were respectively transfected into Saos-2 cells and MG-63 cells to establish the RUSC1-AS1 knockdown or overexpression model. miR-101-3p mimics and the corresponding negative control (NC) (Guangzhou Ribobio) were used to induce miR-101-3p overexpression model. Lipofectamine 2000 reagent (Sangon Biotech) was applied for transfection. 24-hour after transfection, the culture was exchanged with new fresh medium and the cells were continuously incubated for 24 h. Then qRT-PCR was performed to detect RUSC1-AS1, Notch1 and miR-101-3p to ensure the transfection efficiency.
+ Open protocol
+ Expand
3

VEGFA 3'-UTR Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The DNA sequence of the entire human VEGFA 3′-UTR was amplified by polymerase chain reaction (PCR). The amplified DNA sequences were inserted into the p-MIR-report plasmid (Sangon Biotech, Shanghai, China). For luciferase reporter assays, 293T cells were cotransfected with an individual reporter gene (pmiR-Luc-VEGFA-WT, pmiR-Luc-VEGFA-MUT1, or pmiR-Luc-VEGFA-MUT2), a control, or miR-4306 mimics using TransIT-X2 transfection reagent (Invitrogen).
The pGL4.74(hRluc/TK) plasmid, a control luciferase plasmid, and the pGL4.32(luc2P/NF-κB-RE/Hygro) plasmid (Invitrogen) were transfected using Lipofectamine 2000 reagent (Sangon Biotech). A Renilla plasmid (Invitrogen) was used as an internal control for all transfection assays. After transfection for 48 hours, the activities of luciferase and Renilla were tested using a standard protocol (Sangon Biotech).
+ Open protocol
+ Expand
4

Overexpression of PTCSC3 or MIR100HG in Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The vector expressing PTCSC3 or MIR100HG were designed using pcDNA3.1 vector as backbone that was synthesized by Sangon Biotech Co., Ltd. BT-549 and HCC70 cells were seeded in 6-well plates (1×105 cells/well) and transfected with 10 nM vector using Lipofectamine® 2000 reagent (cat. no. 11668-019; Invitrogen; Thermo Fisher Scientific, Inc.). Cells transfected with the empty vectors were used as negative control cells. Non-transfected cells treated with Lipofectamine® 2000 reagent only were used as the control cells. Cells were harvested at 24 h after transfection for subsequent experiments.
+ Open protocol
+ Expand
5

Overexpression of lncRNA-ZNF281 using PcDNA3.1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PcDNA3.1 vector was used to construct an lncRNA-ZNF281 expression vector (Sangon Biotech Co., Ltd.). Negative control (NC; non-targeting cotntrol) miRNA (5′-GUAGUCGAUGCUACGAUCGUAU-3′) and miR-124 mimic (5′-CGUGUUCACAGCGGACCUUGAU-3′) were also purchased from Sangon Biotech Co., Ltd. AGS and SNU-1 cells were harvested at 80% confluence, followed by transfection with 10 nM vector (empty vector as NC group) and 50 nM miRNA (NC miRNA as NC group) into 1×106 cells. All transfections were mediated by Lipofectamine® 2000 reagent (Sangon Biotech Co., Ltd.). The control (C) in all transfections was untransfected cells. Cells were harvested at 24 h post-transfection to perform the following experiments.
+ Open protocol
+ Expand
6

Knockdown and Overexpression of LIPE-AS1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The short-hairpin RNA (shRNA) targeting LIPE-AS1 (sh-LIPE-AS1), LIPE-AS1 over-expressing plasmids, miR-195-5p mimics, and inhibitors as well as their negative controls were obtained from Shanghai GenePharma Co., Ltd. (Shanghai, China). HCC94 and Hela cells were seeded in the 24-well plates with 2 × 105 cells each well. Lipofectamine 2000 reagent (Sangon Biotech, Shanghai, China) was applied for cell transfection according to the manufacturers' protocol.
+ Open protocol
+ Expand
7

Overexpressing miR-93 in Osteosarcoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
PLAC 2 expression vector was constructed using pcDNA3.1 vector (Invitrogen) as the backbone. MiR-93 mimic and negative control (NC) miRNA were purchased from Sigma-Aldrich (USA). MG-63 and U2OS cells were transfected with 40 mM miRNA or 10 mM vector using lipofectamine 2000 reagent (Sangon biotech). Cells without transfections were control (C) cells. Cells transfected with NC miRNA or empty vector were negative control (NC) cells. The following experiments were performed at 24 h post-transfection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!